3553 results for «2336»
3553 results
Current status of renal denervation techniques for the treatment of hypertension (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to review the up-to-date indications, device selection and procedural techniques for renal denervation.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 Hotlines / Late-Breaking Trials in CT-based FFR: DISCOVER FLOW & P3
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in CT-based FFR:
- Ten-year outcomes of coronary lesions assessed by CT angiography derived FFR
- Accuracy of the FFRCT Planner in Complex Coronary Artery Disease
Managing a patient with STEMI and bystander disease in the pandemic (Part 1) - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to be updated on developments in treatment of ACS and STEMI and to discuss diagnosis and treatment for bystander disease.
This session was originally presented during EuroPCR 2021.
The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...
A low-risk patient with a bicuspid type 0 aortic stenosis
18 May 2021 – From EuroPCR 2021
How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!
Two emergencies in one time
18 May 2021 – From EuroPCR 2021
What happened to this 47-year-old man who was still restless, hypoxic, tachypenic, and dependent on oxygen and inotrope even after excellent PCI results? Watch this session to find out more!
Acute STEMI, coronary ectasia and large thrombus burden
18 May 2021 – From EuroPCR 2021
In this session, discover why the combination of DOAC's and DAPT have promising role in the management of large thrombus and coronary ectasia.
Sailing in between the devil and the deep blue sea
18 May 2021 – From EuroPCR 2021
In this session, conduct a reflection on dislodged stents and the best way to deal with such a problem.
Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons
18 May 2021 – From EuroPCR 2021
In this session, analyze culotte stenting in patient with significant distal left main stenosis.
A broken arm swinging in the heart 15 years after transcatheter PFO closure
18 May 2021 – From EuroPCR 2021
This session leads us to question the risks of device arm fracture and to seek the best therapeutic strategies to address these problems.
LM trifurcation STEMI
18 May 2021 – From EuroPCR 2021
Watch the case of this 69-year-old male patient suffering from LM trifurcation with sub-occlusive lesion who presented with severe bradycardia and hypotension after angios: would you have treated him the same way?
Complex treatment of the post MI ventricular septal defect
18 May 2021 – From EuroPCR 2021
This sessions aims at showing why and how percutaneous occlusion of post MI ventricular septal defect can be a feasible alternative approach for patients who are unsuitable for cardiac surgery.
How to treat an occluded radial artery graft
18 May 2021 – From EuroPCR 2021
Watch this session and you will understand why it is essential to always consider revascularization of native vessels once patients are stented in either vein or arterial grafts.
When nightmares become real
18 May 2021 – From EuroPCR 2021
In this session, study the delicate case of a patient facing 3 possible treatment scenarios and find out what the doctor's choice is, and why. CABG, PCI left system first and then RCA, or reverse: would you have chosen the same option?
A young patient with excruciating chest pain and extensive complications
18 May 2021 – From EuroPCR 2021
Try to find out what happens to the presented patient, only 34 years old: spasm, ACS, STEMI occluded diagonal culprit lesion, or spontaneous dissection causing occlusion of diagonal branch? And ask yourself what you would do in such a case!
Exclusion of a huge symptomatic coronary-cameral fistulae
18 May 2021 – From EuroPCR 2021
In this session, find out more about CCF, a rare but major congenital anomaly with potential serious complications undergoing in the older patients.
Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...
Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
